We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 2,393 results
  1. Acute myelitis with multicranial neuritis caused by Varicella zoster virus: a case report

    Background

    Varicella zoster virus (VZV) can remain lifelong in the latent state in ganglionic neurons and adrenal glands after the initial infection....

    Qi Liu, **aomeng Zhou, Zhenfei Li in BMC Neurology
    Article Open access 05 February 2022
  2. A case of paraplegia due to asymptomatic varicella-zoster virus infection in AIDS patient unexpectedly diagnosed by CSF metagenomic next-generation sequencing

    Background

    Varicella-zoster virus (VZV) infection may induce central nervous system complications in HIV/AIDS patients. However, it is rare to have...

    Zhiman **e, **gzhen Lai, ... Hao Liang in BMC Infectious Diseases
    Article Open access 16 September 2021
  3. Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisolone

    Background and purpose

    Optimal treatment of intracranial stenoses in varicella zoster virus (VZV)-associated vasculitis is unknown. This study aims to...

    Markus Kraemer, Daniel Strunk, ... Peter Berlit in Neurological Research and Practice
    Article Open access 16 May 2022
  4. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol

    Background

    The burden of herpes zoster (shingles) virus and associated complications, such as post-herpetic neuralgia, is higher in older adults and...

    Maxime Hentzien, Fabrice Bonnet, ... Alexandra Calmy in BMC Infectious Diseases
    Article Open access 19 March 2024
  5. Reduction in Herpes Zoster Antiviral Use Since the Introduction of the Live-Attenuated Zoster Vaccine on Australia’s National Immunisation Program: A Population-Based Study from 1994 to 2019

    Introduction

    Zostavax, the live-attenuated vaccine used to prevent herpes zoster (HZ), has been available to individuals aged 70 and 71–79 years...

    Sachin Phakey, Sophie L. Rogers, ... Lyndell L. Lim in Infectious Diseases and Therapy
    Article Open access 10 January 2023
  6. Incidence and Burden of Herpes Zoster in Sweden: A Regional Population-Based Register Study

    Introduction

    Herpes zoster (HZ) is a painful disease that mainly affects individuals whose immune system has been weakened because of increasing age...

    Emma Södergren, Kristina Mårdberg, ... Patrik Stäck in Infectious Diseases and Therapy
    Article Open access 09 January 2024
  7. Prevalence of and factors associated with herpes zoster in England: a cross-sectional analysis of the Health Survey for England

    Background

    Herpes zoster (commonly called shingles) is caused by the reactivation of varicella zoster virus, and results in substantial morbidity....

    Sharon L. Cadogan, Jennifer S. Mindell, ... Charlotte Warren-Gash in BMC Infectious Diseases
    Article Open access 01 June 2022
  8. Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019)

    Introduction

    Herpes zoster (HZ) and its complications still represent a significant burden for patients and health care systems. In Spain, vaccination...

    Marta Corcuera-Munguia, Ruth Gil-Prieto, ... Angel Gil-de-Miguel in Infectious Diseases and Therapy
    Article Open access 08 November 2022
  9. Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?

    The first cases of COVID-19 were reported in Wuhan, China, in December 2019. Skin manifestations of COVID-19 vary, among which herpes zoster has...

    Salim Ali Algaadi in Infection
    Article 22 November 2021
  10. Lymphocyte counts predict optimal timing of chemotherapy reinitiation after antivirus treatment for herpes zoster in children with leukemia

    Herpes zoster (HZ) is rare in healthy children, but more prevalent in those with leukemia. Optimal timing of chemotherapy reinitiation after HZ...

    Xuanlu Zhang, Ye Feng, ... **aoming Bai in Archives of Dermatological Research
    Article 01 June 2024
  11. An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report

    Background

    Varicella zoster virus (VZV) causes varicella primarily in childhood, and some rare adults also report varicella. Herpes zoster mainly...

    Guangcheng **e, Qiongling Wei, ... Houguang Liu in BMC Infectious Diseases
    Article Open access 29 June 2020
  12. Herpes simplex and herpes zoster viruses in COVID-19 patients

    Background

    Reactivation of herpes family viruses in immunocompromised patients may result in detrimental outcomes for the hosts; therefore, herpes...

    Joseph Katz, Sijia Yue, Wei Xue in Irish Journal of Medical Science (1971 -)
    Article 11 July 2021
  13. Meningitis retention syndrome caused by varicella zoster virus in a patient without a rash: a case report

    Background

    Meningitis retention syndrome (MRS) is a rare condition that presents with acute urinary retention as a complication of aseptic meningitis....

    Tsuneaki Kenzaka, Ken Goda, Ayako Kumabe in BMC Infectious Diseases
    Article Open access 23 September 2021
  14. Corneal nerve changes in herpes zoster ophthalmicus: a prospective longitudinal in vivo confocal microscopy study

    Purpose

    To study the changes in corneal nerves and corneal sensitivity over a 6-month period in patients with herpes zoster ophthalmicus (HZO)...

    Eugenie Mok, Ka Wai Kam, Alvin L. Young in Eye
    Article 11 March 2023
  15. Visceral disseminated varicella zoster infection: a rare cause of acute abdomen in a patient with well-controlled diabetes mellitus—a case report

    Background

    Visceral disseminated varicella zoster virus (VZV) infections frequently affect immunocompromised patients. Diabetes mellitus has been...

    Daisuke Mizu, Haruka Nishida, ... Koichi Ariyoshi in BMC Infectious Diseases
    Article Open access 03 March 2022
  16. Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies

    Aim

    The risk for Herpes zoster (HZ) and its complications is higher in people with diabetes mellitus (DM). Our aim is to assess efficacy and...

    Giovanni Antonio Silverii, Alessandra Clerico, ... Ilaria Dicembrini in Acta Diabetologica
    Article Open access 20 June 2023
  17. Impfung: Kein erhöhtes Risiko für Herpes zoster

    Redaktion Facharztmagazine in CME
    Article 09 March 2023
  18. Severe acute respiratory syndrome coronavirus 2, primary varicella zoster virus coinfection, and a polymicrobial ventilator-associated tracheobronchitis in an adult immunocompetent male: a case report

    Background

    The spectrum of clinical manifestations and differential diagnosis associated with coronavirus disease 2019 is broad, ranging from fever...

    Jowita Bruno, Silvio Ragozzino, ... Niklaus Labhardt in Journal of Medical Case Reports
    Article Open access 24 January 2022
  19. Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease

    Background

    Disease-related stress can trigger the occurrence of herpes zoster (HZ). Fatty liver disease (FLD) can have adverse effects on the human...

    Cheng-Wei Yu, Chia-Hung Chen, ... Chao-Yu Hsu in European Journal of Medical Research
    Article Open access 02 December 2023
Did you find what you were looking for? Share feedback.